FH Europe seeks a consultant Chief Executive
FH Europe seeks a consultant Chief Executive, home based within continental Europe.
Are you keen to embrace a European consultancy role?
Familial hypercholesterolaemia (FH) is an inherited condition which leads to exceptionally high cholesterol levels, often double and sometimes four times those of the general population. It is easily treated once identified, however the majority of cases remain unknown and at risk of an early heart attack or even death. Around 3m people have the condition in Europe but less than 1% is identified in some countries.
Registered in the UK, FH Europe is a patient network of 24 organisations in 23 countries working together to secure early identification and diagnosis of FH patients.
A fantastic opportunity has arisen for a strategic and inspirational leader to join as a consultant Chief Executive. You will develop, deliver and report on our vision and strategic goals. Leading and ensuring effective delivery of our objectives, activities and facilitating key stakeholder relationships.
The role involves travel throughout Europe and further afield as necessary.
The role is 22.5 hours per week (3 days).
For an informal and confidential discussion about the role, please contact our Chair, Jules Payne +44 7920 804905.
The closing date for applications is 7th October 2019Download Job Description
FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt